Aptinyx Inc. is a biopharmaceutical company discovering and developing innovative therapies for challenging disorders of the brain and nervous system. Aptinyx has a proven platform for discovering proprietary compounds that work through a novel mechanism: modulation of the NMDA receptor to enhance pathways involved with nerve cell communication. This mechanism has applicability across a number of CNS disorders. Our goal is to rapidly advance our most promising drug candidates into clinical development for indications with high unmet medical need.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Aptinyx Inc market cap is $6.5M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Aptinyx Inc 52 week high is $0.72 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Aptinyx Inc 52 week low is $0.009 as of November 22, 2026.
Aptinyx Inc stock price today is $0.096.
Aptinyx Inc stock price yesterday was $0.093.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Aptinyx Inc's P/E ratio is -0.1.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Aptinyx Inc P/B ratio is 0.3561.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Aptinyx Inc 50-day moving average is $0.0675.